Clinical Trial Update: Photobiomodulation on the Salivary Glands of Patients With Xerostomia Induced by the Use of Benzodiazepines [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating photobiomodulation for xerostomia induced by benzodiazepine use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Snippet

Sponsor: University of Nove de Julho | Conditions: Xerostomia | Phase 1, Phase 2 | Status: UNKNOWN